Breakthroughs in the innovative pharmaceutical industry, with policies and capital working together to promote growth.

On August 18, at the Health Industry Capital Summit of the Western Population Health Forum held in Boao, Hainan, industry leaders and investment institutions explored the new value of the pharmaceutical industry focusing on drug research and development, payment innovation, outpatient services, and other core areas. Experts at the meeting believe that the current innovative pharmaceutical industry in China is enjoying multiple advantages such as the highlighted innovation throughout the entire chain, accelerated internationalization process, and continuous policy support. The Chinese medical industry is standing at a new starting point, about to usher in a new wave of growth.